TNFSF11 and Familial prostate cancer: Importantly, in this same set of patients we confirmed a previously reported finding from our laboratory, that the expression of an osteomimicry-related receptor activator of NF-κB ligand (RANKL), also correlated with the survival of prostate cancer patients [22].